Everence Capital Management Inc. Acquires 16,440 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Everence Capital Management Inc. increased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 126.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,460 shares of the company's stock after acquiring an additional 16,440 shares during the period. Everence Capital Management Inc.'s holdings in Henry Schein were worth $2,230,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Cambridge Investment Research Advisors Inc. raised its holdings in shares of Henry Schein by 2.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 5,262 shares of the company's stock worth $459,000 after acquiring an additional 122 shares in the last quarter. Aurora Investment Counsel raised its holdings in Henry Schein by 0.7% during the third quarter. Aurora Investment Counsel now owns 20,641 shares of the company's stock valued at $1,533,000 after buying an additional 140 shares in the last quarter. Arizona State Retirement System raised its holdings in Henry Schein by 0.4% during the fourth quarter. Arizona State Retirement System now owns 35,890 shares of the company's stock valued at $2,717,000 after buying an additional 149 shares in the last quarter. Studio Investment Management LLC raised its holdings in Henry Schein by 3.9% during the fourth quarter. Studio Investment Management LLC now owns 4,160 shares of the company's stock valued at $332,000 after buying an additional 155 shares in the last quarter. Finally, Kentucky Retirement Systems Insurance Trust Fund raised its holdings in Henry Schein by 3.4% during the third quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 4,878 shares of the company's stock valued at $321,000 after buying an additional 161 shares in the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Stock Performance

HSIC stock traded down $1.02 during trading on Wednesday, reaching $70.20. 1,067,027 shares of the stock were exchanged, compared to its average volume of 1,112,613. Henry Schein, Inc. has a twelve month low of $60.01 and a twelve month high of $85.39. The company has a market capitalization of $9.02 billion, a P/E ratio of 22.29, a price-to-earnings-growth ratio of 1.75 and a beta of 0.87. The stock has a 50 day simple moving average of $74.53 and a 200-day simple moving average of $72.50. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing analysts' consensus estimates of $0.70 by ($0.04). The company had revenue of $3.02 billion for the quarter, compared to analyst estimates of $3 billion. Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The firm's revenue for the quarter was down 10.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.21 earnings per share. As a group, sell-side analysts anticipate that Henry Schein, Inc. will post 5.07 earnings per share for the current year.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the sale, the chief executive officer now directly owns 73,108 shares of the company's stock, valued at $5,430,462.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares in the company, valued at $5,430,462.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the business's stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the transaction, the insider now owns 209,562 shares of the company's stock, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. Company insiders own 1.14% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Piper Sandler raised their target price on Henry Schein from $78.00 to $86.00 and gave the company an "overweight" rating in a report on Monday, February 26th. TheStreet upgraded Henry Schein from a "c+" rating to a "b-" rating in a research note on Monday, February 26th. JPMorgan Chase & Co. lifted their price objective on Henry Schein from $82.00 to $88.00 and gave the stock an "overweight" rating in a research note on Wednesday, March 6th. Leerink Partnrs reiterated a "market perform" rating on shares of Henry Schein in a research note on Monday, February 26th. Finally, SVB Leerink initiated coverage on Henry Schein in a research note on Monday, February 26th. They issued a "market perform" rating and a $78.00 price objective on the stock. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $81.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.